Exicure, Inc.
XCUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001698530
No open-market purchases or sales by Exicure, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $306.0K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Exicure, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q4 2022
- Shares held
- 684.9K
- +184.3K (+36.8%) vs. Q4 2022
- Total value
- $594.1K
- +$19.5K (+3.4%) vs. Q4 2022
- New holders
- 2
- 3 more added
- Sold out
- 2
- 5 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XCUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $306.0K |
| Q1 2026 | 19 | $731.4K |
| Q4 2025 | 15 | $803.0K |
| Q3 2025 | 13 | $1.58M |
| Q2 2025 | 15 | $2.62M |
| Q1 2025 | 13 | $4.26M |
| Q4 2024 | 12 | $4.21M |
| Q3 2024 | 12 | $127.3K |
| Q2 2024 | 16 | $171.6K |
| Q1 2024 | 20 | $368.4K |
| Q4 2023 | 16 | $342.0K |
| Q3 2023 | 17 | $470.1K |
| Q2 2023 | 15 | $854.3K |
| Q1 2023 | 15 | $594.1K |
| Q4 2022 | 16 | $898.5K |
| Q3 2022 | 18 | $1.12M |
| Q2 2022 | 18 | $1.56M |
| Q1 2022 | 43 | $5.12M |
| Q4 2021 | 48 | $8.49M |
| Q3 2021 | 47 | $34.9M |
| Q2 2021 | 58 | $44.4M |
| Q1 2021 | 72 | $68.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Exicure, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 80 | $0 | 0.00% | +6+8.1% | Added |
| Wells Fargo & Company | 23 | $20 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,855 | $1.61K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,882 | $1.64K | 0.00% | −9,569−83.6% | Reduced |
| Morgan Stanley | 3,392 | $2.95K | 0.00% | +868+34.4% | Added |
| Tower Research Capital LLC (TRC) | 9,251 | $8.00K | 0.00% | +1,474+19.0% | Added |
| Millennium Management LLC | 10,623 | $9.00K | 0.00% | +10,623 | New |
| BlackRock Inc. | 12,283 | $10.7K | 0.00% | −145−1.2% | Reduced |
| Geode Capital Management, LLC | 22,229 | $19.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 34,318 | $29.9K | 0.00% | −504−1.4% | Reduced |
| Northwestern University | 52,145 | $46.0K | 0.04% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 66,100 | $58.0K | 0.00% | −5,500−7.7% | Reduced |
| Carlson Capital L P | 189,100 | $164.7K | 0.02% | −23,183−10.9% | Reduced |
| Carlyle Group Inc. | 281,636 | $242.2K | 0.01% | +281,636 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −42,816−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,547−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |